PLDT INC-SPON ADR (PHI) Fundamental Analysis & Valuation

NYSE:PHI • US69344D4088

Current stock price

20.95 USD
-0.32 (-1.5%)
Last:

This PHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PHI Profitability Analysis

1.1 Basic Checks

  • In the past year PHI was profitable.
  • In the past year PHI had a positive cash flow from operations.
  • PHI had positive earnings in each of the past 5 years.
  • PHI had a positive operating cash flow in each of the past 5 years.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B 60B 80B

1.2 Ratios

  • PHI has a Return On Assets of 4.72%. This is comparable to the rest of the industry: PHI outperforms 59.09% of its industry peers.
  • With an excellent Return On Equity value of 23.60%, PHI belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 8.80%, PHI is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
  • PHI had an Average Return On Invested Capital over the past 3 years of 8.58%. This is in line with the industry average of 7.40%.
  • The 3 year average ROIC (8.58%) for PHI is below the current ROIC(8.80%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.72%
ROE 23.6%
ROIC 8.8%
ROA(3y)4.75%
ROA(5y)4.02%
ROE(3y)25.59%
ROE(5y)21.54%
ROIC(3y)8.58%
ROIC(5y)7%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 13.72%, PHI belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • In the last couple of years the Profit Margin of PHI has remained more or less at the same level.
  • With an excellent Operating Margin value of 25.08%, PHI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • PHI's Operating Margin has improved in the last couple of years.
  • PHI has a Gross Margin of 86.80%. This is amongst the best in the industry. PHI outperforms 86.36% of its industry peers.
  • PHI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.08%
PM (TTM) 13.72%
GM 86.8%
OM growth 3Y131.46%
OM growth 5Y2.7%
PM growth 3Y39.05%
PM growth 5Y0.49%
GM growth 3Y-1.15%
GM growth 5Y-1.05%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. PHI Health Analysis

2.1 Basic Checks

  • PHI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • PHI has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PHI has about the same amount of shares outstanding.
  • The debt/assets ratio for PHI is higher compared to a year ago.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B

2.2 Solvency

  • PHI has an Altman-Z score of 0.88. This is a bad value and indicates that PHI is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.88, PHI is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • The Debt to FCF ratio of PHI is 10.07, which is on the high side as it means it would take PHI, 10.07 years of fcf income to pay off all of its debts.
  • PHI's Debt to FCF ratio of 10.07 is on the low side compared to the rest of the industry. PHI is outperformed by 68.18% of its industry peers.
  • A Debt/Equity ratio of 2.63 is on the high side and indicates that PHI has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.63, PHI is doing worse than 77.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.63
Debt/FCF 10.07
Altman-Z 0.88
ROIC/WACC2.86
WACC3.08%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100B 200B 300B

2.3 Liquidity

  • PHI has a Current Ratio of 0.44. This is a bad value and indicates that PHI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PHI has a Current ratio of 0.44. This is amonst the worse of the industry: PHI underperforms 95.45% of its industry peers.
  • PHI has a Quick Ratio of 0.44. This is a bad value and indicates that PHI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.42, PHI is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.42
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. PHI Growth Analysis

3.1 Past

  • PHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.58%.
  • PHI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.18% yearly.
  • The Revenue has been growing slightly by 0.72% in the past year.
  • The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)6.58%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%16.65%
Revenue 1Y (TTM)0.72%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%-1.41%

3.2 Future

  • PHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.45% yearly.
  • PHI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.05% yearly.
EPS Next Y-1.81%
EPS Next 2Y0.87%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue Next Year1.42%
Revenue Next 2Y1.88%
Revenue Next 3Y2.05%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

More info and screens

Find the best growth stocksShow best growing peers

8

4. PHI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.85 indicates a rather cheap valuation of PHI.
  • 100.00% of the companies in the same industry are more expensive than PHI, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of PHI to the average of the S&P500 Index (25.60), we can say PHI is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 7.71, the valuation of PHI can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, PHI is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of PHI to the average of the S&P500 Index (22.84), we can say PHI is valued rather cheaply.
Industry RankSector Rank
PE 7.85
Fwd PE 7.71
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHI indicates a somewhat cheap valuation: PHI is cheaper than 77.27% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHI indicates a rather cheap valuation: PHI is cheaper than 86.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.69
EV/EBITDA 5.43
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The excellent profitability rating of PHI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.52
EPS Next 2Y0.87%
EPS Next 3Y1.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. PHI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.26%, PHI is a good candidate for dividend investing.
  • PHI's Dividend Yield is a higher than the industry average which is at 6.58.
  • Compared to an average S&P500 Dividend Yield of 1.88, PHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.26%

5.2 History

  • The dividend of PHI has a limited annual growth rate of 3.96%.
  • PHI has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)3.96%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • PHI pays out 68.74% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of PHI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP68.74%
EPS Next 2Y0.87%
EPS Next 3Y1.45%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PHI Fundamentals: All Metrics, Ratios and Statistics

PLDT INC-SPON ADR

NYSE:PHI (4/2/2026, 8:04:00 PM)

20.95

-0.32 (-1.5%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-26
Earnings (Next)05-13
Inst Owners5.24%
Inst Owner Change0.52%
Ins Owners0.81%
Ins Owner Change0%
Market Cap4.53B
Revenue(TTM)218.39B
Net Income(TTM)29.95B
Analysts82.5
Price Target28.52 (36.13%)
Short Float %0.23%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield 7.26%
Yearly Dividend1.57
Dividend Growth(5Y)3.96%
DP68.74%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-25
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.51%
EPS NQ rev (1m)-3.82%
EPS NQ rev (3m)1.02%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 7.85
Fwd PE 7.71
P/S 1.26
P/FCF 7.69
P/OCF 2.78
P/B 2.16
P/tB 4.39
EV/EBITDA 5.43
EPS(TTM)2.67
EY12.74%
EPS(NY)2.72
Fwd EY12.96%
FCF(TTM)2.72
FCFY13%
OCF(TTM)7.54
OCFY35.99%
SpS16.68
BVpS9.69
TBVpS4.77
PEG (NY)N/A
PEG (5Y)1.52
Graham Number24.13
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 23.6%
ROCE 11.52%
ROIC 8.8%
ROICexc 9.03%
ROICexgc 10.49%
OM 25.08%
PM (TTM) 13.72%
GM 86.8%
FCFM 16.33%
ROA(3y)4.75%
ROA(5y)4.02%
ROE(3y)25.59%
ROE(5y)21.54%
ROIC(3y)8.58%
ROIC(5y)7%
ROICexc(3y)8.85%
ROICexc(5y)7.45%
ROICexgc(3y)10.42%
ROICexgc(5y)8.87%
ROCE(3y)11.23%
ROCE(5y)9.16%
ROICexgc growth 3Y111.98%
ROICexgc growth 5Y-3.02%
ROICexc growth 3Y115.78%
ROICexc growth 5Y-1.38%
OM growth 3Y131.46%
OM growth 5Y2.7%
PM growth 3Y39.05%
PM growth 5Y0.49%
GM growth 3Y-1.15%
GM growth 5Y-1.05%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 2.63
Debt/FCF 10.07
Debt/EBITDA 2.92
Cap/Depr 106.04%
Cap/Sales 28.88%
Interest Coverage 4.14
Cash Conversion 86.41%
Profit Quality 119.05%
Current Ratio 0.44
Quick Ratio 0.42
Altman-Z 0.88
F-Score4
WACC3.08%
ROIC/WACC2.86
Cap/Depr(3y)120.38%
Cap/Depr(5y)129.36%
Cap/Sales(3y)32.52%
Cap/Sales(5y)39.68%
Profit Quality(3y)62.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.58%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%16.65%
EPS Next Y-1.81%
EPS Next 2Y0.87%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)0.72%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%-1.41%
Revenue Next Year1.42%
Revenue Next 2Y1.88%
Revenue Next 3Y2.05%
Revenue Next 5YN/A
EBIT growth 1Y3.71%
EBIT growth 3Y136.64%
EBIT growth 5Y6.63%
EBIT Next Year102.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y165.21%
FCF growth 3YN/A
FCF growth 5Y38.58%
OCF growth 1Y20.81%
OCF growth 3Y9.02%
OCF growth 5Y3.02%

PLDT INC-SPON ADR / PHI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PLDT INC-SPON ADR?

ChartMill assigns a fundamental rating of 5 / 10 to PHI.


What is the valuation status for PHI stock?

ChartMill assigns a valuation rating of 8 / 10 to PLDT INC-SPON ADR (PHI). This can be considered as Undervalued.


Can you provide the profitability details for PLDT INC-SPON ADR?

PLDT INC-SPON ADR (PHI) has a profitability rating of 8 / 10.


How financially healthy is PLDT INC-SPON ADR?

The financial health rating of PLDT INC-SPON ADR (PHI) is 1 / 10.


What is the expected EPS growth for PLDT INC-SPON ADR (PHI) stock?

The Earnings per Share (EPS) of PLDT INC-SPON ADR (PHI) is expected to decline by -1.81% in the next year.